OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 64 filers reported holding OPHTHOTECH CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $166,552,000 | -9.6% | 3,610,487 | 0.0% | 14.79% | -23.5% |
| Q2 2016 | $184,243,000 | -11.2% | 3,610,487 | -26.5% | 19.34% | -15.0% |
| Q1 2016 | $207,566,000 | -46.2% | 4,910,487 | 0.0% | 22.75% | -38.6% |
| Q4 2015 | $385,621,000 | +93.8% | 4,910,487 | 0.0% | 37.06% | +80.3% |
| Q3 2015 | $198,973,000 | -22.2% | 4,910,487 | 0.0% | 20.56% | +11.8% |
| Q2 2015 | $255,640,000 | +11.9% | 4,910,487 | 0.0% | 18.38% | -5.4% |
| Q1 2015 | $228,485,000 | -13.7% | 4,910,487 | -16.8% | 19.43% | -9.3% |
| Q4 2014 | $264,815,000 | -1.4% | 5,901,819 | -14.4% | 21.42% | -18.2% |
| Q3 2014 | $268,493,000 | -54.0% | 6,896,819 | -50.0% | 26.18% | -10.5% |
| Q2 2014 | $584,187,000 | +18.6% | 13,807,308 | 0.0% | 29.24% | -4.9% |
| Q1 2014 | $492,541,000 | +10.3% | 13,807,308 | 0.0% | 30.74% | -7.8% |
| Q4 2013 | $446,666,000 | – | 13,807,308 | – | 33.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,053,143 | $95,533,000 | 31.57% |
| Clarus Ventures, LLC | 1,554,744 | $72,342,000 | 30.07% |
| Novo Holdings A/S | 4,910,487 | $228,485,000 | 19.43% |
| JHL Capital Group LLC | 3,265,000 | $151,920,000 | 13.98% |
| AlpInvest Partners B.V. | 37,500 | $1,745,000 | 3.26% |
| Opaleye Management Inc. | 105,000 | $4,886,000 | 2.27% |
| IMA Wealth, Inc. | 67,930 | $3,161,000 | 1.54% |
| Hillview Capital Advisors, LLC | 34,830 | $1,621,000 | 1.40% |
| Cheyne Capital Management (UK) LLP | 124,151 | $5,777,000 | 1.39% |
| WILLIAM HARRIS INVESTORS INC | 106,158 | $4,939,000 | 1.30% |